By contrast, in MetS group 50% of the individuals had the Adpn/Lep ratio < 0.5, 30% fell within the normal range and 20% of the patients presented values ≥ 0.5 or < 1.0, which can suggest a moderate-medium increased risk of cardiometabolic disorders (Fig. 2). Here, ADIPOQ is linked to metabolic syndrome.